Rapid amperometric verification of PCR amplification of DNA

• US 6,638,716 B2
• Filed: 08/24/1998
• Issued: 10/28/2003
• Est. Priority Date: 08/24/1998
• Status: Expired due to Term

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Therasense Incorporated (Abbott Laboratories)
• Inventors: Georgiou, George, Freeman, Amihay, de Lumley-Woodyear, Thierry, Heller, Adam
• Primary Examiner(s): FORMAN, BETTY J
• Assistant Examiner(s): Taylor, Janell
• Application Number:
  US09/145,776
• Publication Number:
  US 20020001799A1
• Time in Patent Office: 1,891 Days
• Field of Search: 435/6, 435/7, 435/803, 435/817, 435/810, 435/29, 435/34, 435/289.1, 935/78, 935/81, 436/501, 436/808, 436/63, 204/403, 204/415, 204/290, 204/291, 204/292
• US Class Current: 435/6.18
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence
• CPC Class Codes: C12Q 1/6825 Nucleic acid detection involving sensors
• CPC Class Codes: Y10S 435/803 Physical recovery methods, e.g. chromatography, grinding
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/817 Enzyme or microbe electrode
• CPC Class Codes: Y10S 436/808 Automated or kit

Abstract

Rapid electrochemical verification of the amplification of DNA by a polymerase chain reaction in a small sample of the PCR product.

Claims

1. A method for verifying amplification of a nucleic acid molecule in a sample, comprising:

synthesizing, in an amplification process, a nucleic acid molecule labeled with a first ligand and with a second ligand;

immobilizing the nucleic acid molecule on an electrode by binding the first ligand to a redox polymer film disposed on the electrode;

binding a detection marker comprising a catalyst to the second ligand; and

correlating a change in current or potential at the electrode with a change in the rate of an electrochemical reaction catalyzed by the detection marker catalyst and with amplification of the nucleic acid molecule,

wherein the correlating step is accomplished without separating immobilized nucleic acid molecules from the sample.

2. The method of claim 1 where said correlating a change comprises measuring an electrical current.

3. The method of claim 1 where said correlating a change comprises measuring an electrical potential.

4. The method of claim 1, where the catalyst is an enzyme.

5. The method of claim 4 where the enzyme is an oxidoreductase.

6. The method of claim 5 where a substrate of the oxidoreductase is oxidized by the electrooxidized redox polymer or electroreduced by the electroreduced redox polymer.

7. The method of claim 6 where the oxidoreductase is a peroxidase and the substrate is hydrogen peroxide.

8. The method of claim 6 where the oxidoreductase is an oxidase.

9. The method of claim 4 where the enzyme catalyzes the hydrolysis of a substrate to a product, the product being electrooxidized at a less oxidizing potential than the substrate.

10. The method of claim 1, wherein said catalyst comprises a peroxidase.

11. The method of claim 10, wherein said peroxidase is thermostable.

12. The method of claim 11, wherein the thermostable peroxidase is soybean peroxidase.

13. The method of claim 1, wherein said redox polymer comprises a binding agent covalently bound thereto, and wherein binding of the first ligand to the redox polymer comprises binding the first ligand to the binding agent.

14. The method of claim 13, wherein said binding agent comprises avidin, streptavidin, an antibody or an antibody fragment.

15. The method of claim 1, wherein said detection marker further comprises avidin, streptavidin, an antibody or a fragment of an antibody.

16. The method of claim 1, wherein the redox polymer film is hydrated.

17. The method of claim 16, wherein the weight of water in the hydrated redox polymer is more than 10% of the weight of the redox polymer.

18. The method of claim 1, wherein the amplification process is carried out with a mixture comprising a ligand labeled primer.

19. The method of claim 18, wherein the amplification process is carried out with a first primer labeled with a first ligand and with a second primer labeled with a second ligand, the first primer differing from the second primer and the first ligand differing from the second ligand.

20. The method of claim 19, wherein the second ligand comprises a biotin function.

21. The method of claim 19, wherein the first ligand or the second ligand comprises a biotin function.

22. The method of claim 13, wherein said first ligand comprises digoxigenin and said binding agent comprises an anti-digoxin antibody.

23. The method of claim 1, wherein said second ligand comprises biotin, and wherein said detection marker comprises a biotin function.

24. The method of claim 22, wherein said detection marker comprises peroxidase.